Veradigm | MDRX - Vertriebs- Und Verwaltungskosten

Aktienkurs
4.46
Täglich Wechseln
-0.29 -6.11%
Monatlich
4.21%
Jährlich
3.72%
Q2 Prognose
4.37




Vertriebs- Und Verwaltungskosten Veränderung Datum
Alcidion AUD 1.09M 184K 2025-12
Ambu A/S DKK 689M 50M 2025-12
Cardinal Health USD 1.51B 6M 2026-03
Centene USD 3.4B 27M 2026-03
Charles River Laboratories USD 159.42M 36.71M 2026-03
Cigna USD 3.32B 291M 2026-03
Coloplast 2.64B 52M 2025-12
Computer Programs Systems USD 51.62M 109.74M 2025-12
Convatec Group USD 420.3M 210.35M 2024-12
Diasorin EUR 105.25M 5.1M 2025-12
Elevance Health USD 10.91B 309M 2025-12
General Electric Aerospace USD 1.08B 496M 2026-03
Gulf Medical Proj AED 915K 52K 2025-12
Humana USD 3.36B 614M 2025-03
IQVIA Holdings USD 502M 34M 2026-03
Laboratory Of America USD 551M 12.4M 2026-03
Maximus USD 173.48M 21.32M 2026-03
McKesson USD 1.8B 234M 2026-03
Med Life RON 23.07M 3.23M 2025-09
Molina Healthcare USD 3.77B 2.43B 2026-03
Omnicell USD 101.99M 5.37M 2026-03
Oriola-kd EUR 13M 3.1M 2025-09
Owens Minor USD 258.98M 7.5M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Rede D'or Sao Luiz BRL 69.46M 513.18M 2025-12
Siemens Healthineers EUR 963M 38M 2026-03
Sonova Holding CHF 880.2M 300K 2025-06
UnitedHealth USD 15.22B 1.44B 2025-09
Veeva Systems USD 125.08M 3.11M 2025-12
Veradigm USD 27.28M 5.24M 2022-12
Xerox USD 368M 10M 2025-06